Barclays’s Morphic Holding, Inc. Common Stock MORF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-88,766
| Closed | -$3.02M | – | 5557 |
|
|
2024
Q2 | $3.02M | Buy |
88,766
+44,039
| +98% | +$1.3M | ﹤0.01% | 1851 |
|
|
2024
Q1 | $1.57M | Sell |
44,727
-85,660
| -66% | -$2.87M | ﹤0.01% | 2768 |
|
|
2023
Q4 | $3.77M | Buy |
130,387
+56,389
| +76% | +$1.34M | ﹤0.01% | 2362 |
|
|
2023
Q3 | $1.7M | Buy |
73,998
+7,004
| +10% | +$368K | ﹤0.01% | 1994 |
|
|
2023
Q2 | $3.84M | Buy |
66,994
+35,718
| +114% | +$1.87M | ﹤0.01% | 1501 |
|
|
2023
Q1 | $1.18M | Sell |
31,276
-31,152
| -50% | -$1.15M | ﹤0.01% | 2605 |
|
|
2022
Q4 | $1.67M | Buy |
62,428
+3,260
| +6% | +$89.1K | ﹤0.01% | 2384 |
|
|
2022
Q3 | $1.68M | Buy |
59,168
+57,877
| +4,483% | +$1.61M | ﹤0.01% | 1875 |
|
|
2022
Q2 | $28K | Sell |
1,291
-2,323
| -64% | -$64.9K | ﹤0.01% | 4276 |
|
|
2022
Q1 | $145K | Sell |
3,614
-22,071
| -86% | -$924K | ﹤0.01% | 3609 |
|
|
2021
Q4 | $1.22M | Buy |
25,685
+16,149
| +169% | +$866K | ﹤0.01% | 2702 |
|
|
2021
Q3 | $540K | Buy |
9,536
+3,992
| +72% | +$242K | ﹤0.01% | 3151 |
|
|
2021
Q2 | $318K | Sell |
5,544
-6,100
| -52% | -$336K | ﹤0.01% | 3324 |
|
|
2021
Q1 | $737K | Buy |
11,644
+7,147
| +159% | +$328K | ﹤0.01% | 2952 |
|
|
2020
Q4 | $151K | Sell |
4,497
-1,787
| -28% | -$52.8K | ﹤0.01% | 3930 |
|
|
2020
Q3 | $172K | Sell |
6,284
-1,248
| -17% | -$32.7K | ﹤0.01% | 3937 |
|
|
2020
Q2 | $203K | Buy |
7,532
+3,973
| +112% | +$74.4K | ﹤0.01% | 4062 |
|
|
2020
Q1 | $52K | Sell |
3,559
-1,386
| -28% | -$23.2K | ﹤0.01% | 5214 |
|
|
2019
Q4 | $85K | Buy |
4,945
+2,308
| +88% | +$36K | ﹤0.01% | 5553 |
|
|
2019
Q3 | $48K | Buy |
+2,637
| New | +$55.3K | ﹤0.01% | 5927 |
|
Other funds holding MORF
Barclays's MORF Position: Q3 2024 in Review
Barclays sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 88,766 shares — an estimated $3.02M sold.
Barclays first reported a position in MORF in Q3 2019 and held it in 20 quarters. The position peaked at $3.84M in Q2 2023. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.
- Barclays reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Barclays sold 88,766 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $3.02M.
- Barclays first reported a position in Morphic Holding, Inc. Common Stock in Q3 2019 and held it in 20 quarters.
- Barclays's Morphic Holding, Inc. Common Stock position peaked at $3.84M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.